Full Coverage

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

                   
prnewswire.com
May 22, 2008
        
Story Timeline:  197 days

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors Rigel Pharmaceuticals CMO to Add Valuable Clinical Development Expertise SAN DIEGO, May 22 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor... [read full story]                    

Add Comment
Latest article on this story:

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

 genengnews.com May 22, 2008
First article on this story:

SAN DIEGO--- VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

 freshnews.com May 22, 2008
Selected publications with coverage of this story:
redorbit.com prnewswire.com yahoo.com earthtimes.org freshnews.com genengnews.com pharmiweb.co.uk
RELATED
Found 5 documents:

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

genengnews.com
May 22, 2008
        

PRNEWSWIRE SAN DIEGO, May 22 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the appointment of Dr. Elliott...

                   

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

redorbit.com
May 22, 2008
        

SAN DIEGO, May 22 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the appointment of Dr.

                   

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors (PR Newswire)

yahoo.com
May 22, 2008
        

Thursday May 22, 6:00 am ET Rigel Pharmaceuticals CMO to Add Valuable Clinical Development Expertise SAN DIEGO, May 22 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer,...

                   

VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

earthtimes.org
May 22, 2008
        

SAN DIEGO, May 22 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the appoint...

                   

SAN DIEGO--- VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors

freshnews.com
May 22, 2008
        

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the appointment of Dr. Elliott Grossbard to its Board of Directors. "We are pleased...